Main Article Content
Bartter syndrome is an inherited renal tubular disorder caused by a defective salt reabsorption in the thick ascending limb of loop of Henle. It characterized by urinary loss of sodium, potassium, and chloride; hypokalemic metabolic alkalosis; normal blood pressure, high plasma levels of renin and aldosterone. There is phenotypical and genetic variability of Bartter syndrome since were identified five genes responsible for five different forms of Bartter syndrome. The objective of this work is to report a clinical case to study the pathophysiological, clinical, biological and therapeutic features of this syndrome.
Materials and Methods: We reported a case of 04-month-old male infant admitted for acute dehydration secondary to polyuro-polydipsia syndrome and vomiting. In clinical presentation the patient had a dysmorphic syndrome with triangular face, protruding ears and flattened nasal root. Laboratory tests revealed hypokalemia, hyponatremia, metabolic alkalosis and hypercalciuria. Treatment with indomethacin was started at 1 mg/kg per day with favorable outcome.
Bartter Syndrome Syed Rizwan A. Bokhari , Hassam Zulfiqar , Abeera Mansur In: Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Apr 23.)
Seyberth HW. Pathophysiology and clinical presentations of salt-losing tubulopathies. Pediatr Nephrol. 2016;31:407–418.
Larkins N, Wallis M, McGillivray B, Mammen C. A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin. Clin Kidney J. 2014;7:306–310.
Kömhoff, Martin & Laghmani, Kamel. Pathophysiology of Antenatal Bartter's Syndrome. Current opinion in nephrology and hypertension. 26. 10.1097/MNH. 0000000000000346; 2017.
Tamara da Silva Cunha and Ita Pfeferman Heilberg. Bartter syndrome: causes, diagnosis, and treatment. International Journal of Nephrology and Renovascular Disease. 2018;11:291–301
Blanchard A, et al. Syndromes de Bartter–Gitelman. Néphrol ther; 2020. Available:https://doi.org/10.1016/ j.nephro.2020.06.001)
Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, et al. Clinical and genetic spectrum of bartter syndrome Type 3. J Am Soc Nephrol. 2017;28:2540–52.
Nagao R, Suzuki S, Kawashima H, Nozu K, Iijima K. Acute kidney injury in type 3 Bartter syndrome: angiotensin-converting enzyme inhibitors as a cause. Pediatr Int. 2016;58(12):1373–1374.
Rosanna Fulchiero, et al. Bartter Syndrome and Gitelman Syndrome. Pediatr Clin N Am. 2019;66:121–134.
Buyukcelik M, Keskin M, Kilic BD, et al. Bartter syndrome and growth hormonedeficiency: Three cases. Pediatr Nephrol. 2012;27:2145–8.
Gil-Pen˜a H, Garcia-Lopez E, Alvarez-Garcia O, et al. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: Effect of growth hormone treatment. Am J Physiol Renal Physiol. 2009;297:639.
Richmond E, Rogol AD. Current indications for growth hormone therapy for children and adolescents. Endocr Dev. 2010;18:92–108.
H. Aloulou et al. Le syndrome de Bartter chez l’enfant: Étude de trois observations. Journal de pédiatrie et de puériculture. 2009;22:55—61.